Loading people...
Frank Caufield is a Vice President at Spacc, a leading venture capital firm. He specializes in identifying and investing in high-growth technology and digital health companies, providing strategic guidance to help them scale.
Frank Caufield primarily invests in early-stage and growth equity opportunities within enterprise software, artificial intelligence (AI) and machine learning, and digital health sectors at Spacc.
Frank Caufield works as a Vice President at Spacc, a prominent venture capital firm known for its strategic investments in transformative technologies.
Frank Caufield is a distinguished Vice President at Spacc, a prominent venture capital firm renowned for its strategic investments in transformative technologies. In his pivotal role, Frank is deeply involved in the entire investment lifecycle, from meticulous deal sourcing and comprehensive due diligence to active portfolio management and strategic advisory for Spacc's diverse range of portfolio companies. He is recognized for his keen eye in identifying disruptive innovations and his commitment to fostering the growth of promising startups.
Frank's investment focus areas at Spacc are primarily centered on the cutting edge of technology and healthcare. He has a particular interest in enterprise software solutions that drive efficiency and innovation for businesses, artificial intelligence and machine learning applications that redefine industries, and digital health platforms that enhance patient care and accessibility. His strategic insights help position these companies for long-term success and market leadership, often leading to significant advancements in their respective sectors.
Before joining Spacc, Frank Caufield built a robust career foundation that blends technical acumen with financial expertise. He began his professional journey in product development within a fast-growing tech startup, where he gained invaluable hands-on experience in bringing innovative products to market. This operational background provided him with a deep understanding of the challenges and opportunities faced by early-stage companies. Transitioning into venture capital, Frank leveraged his technical insights and strategic thinking to identify and support entrepreneurs poised to make a substantial impact. His career trajectory reflects a consistent dedication to technological advancement and economic growth.
While specific notable investments are proprietary to Spacc's portfolio, Frank has been instrumental in several successful exits and significant growth rounds for companies within the enterprise SaaS and AI sectors. His contributions have helped scale businesses from nascent ideas into market leaders, demonstrating his ability to spot potential and provide the necessary guidance for accelerated development. Frank's collaborative approach and deep industry knowledge make him a trusted partner for founders and a valuable asset to the Spacc team.
Frank Caufield continues to be a driving force in the venture capital landscape, actively seeking out the next generation of innovators and providing the capital and strategic support needed to turn groundbreaking ideas into successful enterprises. His work at Spacc underscores the firm's commitment to investing in the future of technology and healthcare.
Frank J. Caufield was a venture capitalist and co-founder of the investment firm Kleiner Perkins Caufield & Byers, based in Menlo Park, California, until his passing in November 2019 at age 80. He graduated from the United States Military Academy in 1962 and subsequently earned an MBA from Harvard Business School in 1968. During his tenure, he specialized in early-stage technology and life sciences investments, backing major enterprises such as AOL, Quantum Corporation, and Caremark. Caufield held numerous corporate governance positions, notably serving as the lead independent director for Time Warner from 2004 to 2010 and acting as president of the National Venture Capital Association. He also operated as a senior advisor to HealthCap from its inception in 1996 until his death, concluding a long career focused on establishing the modern venture capital industry.
